The VC Outlook: Q3’24 Recap & Emerging Market Trends
In this webinar, our expert dives into venture activity, highlighting the emerging trends our data is signaling.
In this webinar, our expert dives into venture activity, highlighting the emerging trends our data is signaling.
Healthcare incumbents, big tech, and startups alike are using AI to address key pain points in clinical workflows. We break down the fast-growing market for ambient AI solutions in healthcare.
This report uses the CB Insights TECH Framework to rank clinical trials markets based on current commercial readiness and momentum.
We surveyed 50 strategy team leaders to identify their key challenges — and the tactics they use to overcome them. Here’s what the most successful teams are doing to influence their organizations.
From rapid, on-site diagnostics to novel stem cell therapies, animal health is seeing a wave of innovations to prevent, diagnose, and treat disease.
Using CB Insights data, we sifted through thousands of startups to find the ones with the most impressive business momentum, founding teams, and exit potential.
Electric vertical take-off and landing aircraft have a lot of potential benefits for quickly covering short distances, though big challenges remain. We examine the market’s driving forces, recent advancements, and the industries most impacted.
Bet on the right digital health markets. Dig into your rivals’ health tech strategies. Identify the best digital health startups.
Discover the 52 emerging tech startups on track for a successful exit, and learn how they’re transforming industries.
The Insurtech 50 is CB Insights’ annual list of the 50 most promising private insurtech companies in the world. This year’s winners are working on everything from AI assistants to embedded insurance.
In 2024 so far, Andreessen Horowitz’s leading AI priorities are multimedia generation and AI-fueled agents & copilots.
Big tech is revolutionizing healthcare. Our expert breaks down their strategies, and how they’re shaping the future of the industry.
From protocol design to real-world data, we map the 96 tech companies making clinical trials faster, cheaper, and more patient-centric.
Using CB Insights proprietary data signals, we identified promising startups across 12 categories aiming to expand lifespans, from human cryopreservation to cellular reprogramming.
Insurtech funding sees its strongest quarter in over a year despite deal volume sinking to its lowest point since 2016.
From medical scribes to clinical trial platforms, AI-driven solutions are key targets of digital health M&A deals in 2024 so far. Here’s where we’re seeing the most activity.
Our expert explains how AI agents are tackling enterprise workflows across industries and the key trends to watch.
$100M+ mega-rounds drive growth in corporate venture capital-backed funding in Q2’24, while deal activity falters.
AI funding hits $23.2B in Q2’24 — the highest quarterly level on record.
In-Q-Tel’s investment activity has implications for the private and public sectors. We mined its bets since Q2’22 to uncover the technologies it’s prioritizing, from biological computing to AI security.
As concerns mount around the rise of counterfeit drugs, supply chain technologies such as IoT asset tracking, blockchain ledgers, and product & packaging authentication can provide pharma companies with more visibility and supply chain security.
We explore how insurers are using genAI to improve customer experience, employee productivity, and underwriting.
Funding in digital health drops, but larger check sizes and an uptick in exits highlight bright spots for the industry in Q2’24.
Assess how prepared US health systems are to adopt and respond to rapidly evolving AI technologies.
Midway through 2024, AI startups continue to steal the show. Now, our expert is diving into the trends shaping the space.
AI startups steal the show, grabbing over a third of all funding, while the rest of the venture ecosystem remains tepid in Q2’24.